Sargent Investment Group, LLC Spectrum Pharmaceuticals Inc Transaction History

Sargent Investment Group, LLC

$546 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$0.65 - $1.31 $83,850 - $168,990	-129,000 Reduced 11.68%	975,600 $936,000
Q1 2023 May 02, 2023	BUY	$0.38 - $1.07 $243,200 - $684,800	640,000 Added 137.75%	1,104,600 $828,000
Q4 2022 Jan 31, 2023	SELL	$0.32 - $0.52 $35,200 - $57,200	-110,000 Reduced 19.14%	464,600 $171,000
Q3 2022 Oct 26, 2022	SELL	$0.43 - $1.56 $17,200 - $62,400	-40,000 Reduced 6.51%	574,600 $252,000
Q2 2022 Jul 26, 2022	BUY	$0.7 - $1.4 $140,000 - $280,000	200,000 Added 48.24%	614,600 $479,000
Q1 2022 May 06, 2022	BUY	$0.63 - $1.59 $252,000 - $636,000	400,000 Added 2739.73%	414,600 $535,000
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $182,880 - $348,480	-144,000 Reduced 90.79%	14,600 $19,000
Q3 2021 Nov 12, 2021	SELL	$2.15 - $3.82 $12,093 - $21,487	-5,625 Reduced 3.43%	158,600 $346,000
Q2 2021 Aug 05, 2021	BUY	$2.89 - $4.45 $19,363 - $29,815	6,700 Added 4.25%	164,225 $616,000
Q1 2021 May 04, 2021	SELL	$2.9 - $4.09 $49,300 - $69,530	-17,000 Reduced 9.74%	157,525 $514,000
Q4 2020 Feb 10, 2021	SELL	$3.38 - $5.14 $248,159 - $377,378	-73,420 Reduced 29.61%	174,525 $595,000
Q3 2020 Nov 12, 2020	BUY	$2.99 - $4.9 $279,864 - $458,640	93,600 Added 60.64%	247,945 $1.01 Million
Q2 2020 Aug 11, 2020	SELL	$2.11 - $3.38 $28,748 - $46,052	-13,625 Reduced 8.11%	154,345 $564,000
Q1 2020 May 12, 2020	SELL	$1.83 - $3.45 $77,226 - $145,590	-42,200 Reduced 20.08%	167,970 $391,000
Q4 2019 Feb 11, 2020	BUY	$3.5 - $10.35 $105,350 - $311,535	30,100 Added 16.72%	210,170 $764,000
Q4 2019 Jan 30, 2020	SELL	$3.5 - $10.35 $1.24 Million - $3.68 Million	-355,575 Reduced 66.38%	180,070 $655,000
Q3 2019 Oct 29, 2019	BUY	$7.03 - $9.7 $514,877 - $710,428	73,240 Added 15.84%	535,645 $4.44 Million
Q2 2019 Aug 12, 2019	SELL	$7.36 - $11.26 $44,160 - $67,560	-6,000 Reduced 1.28%	462,405 $3.98 Million
Q1 2019 May 13, 2019	BUY	$9.08 - $11.84 $185,322 - $241,654	20,410 Added 4.56%	468,405 $5.01 Million
Q4 2018 Feb 12, 2019	BUY	$6.39 - $16.99 $2.86 Million - $7.61 Million	447,995 New	447,995 $3.92 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Account